Wouter V. Vogel
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
Clinical impact of routine second‑opinion reading of [¹⁸F]FDG‑PET/CT in newly diagnosed invasive bladder cancer: A multicentre study in a centralised referral network.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 06, 2026
Insights from an unfortunate FDG contamination.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 15, 2026
Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 18, 2026
Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 18, 2026
PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 12, 2026
Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.
Journal: Clinical and translational radiation oncology
Published: January 07, 2026
Oncological outcomes following PSMA PET/CT-guided salvage whole-pelvis radiotherapy for recurrent prostate cancer.
Journal: Clinical and translational radiation oncology
Published: December 23, 2025
Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer.
Journal: European urology oncology
Published: October 12, 2025
Last Updated: 09/26/2026